Rini Sekartini

Prof. Rini Sekartini

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2013 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
JMJodi A Mindell
Jodi A Mindell
ABAlex Bartle
Alex Bartle
YAYoungmin Ahn
Youngmin Ahn
MRMahesh Babu Ramamurthy
Mahesh Babu Ramamurthy
HHHuynh Thi Duy Huong
Huynh Thi Duy Huong
DGDaniel Yt Goh
Daniel Yt Goh
The objective of this study was to assess the prevalence of education about sleep and sleep disorders in pediatric residency programs and to identify barriers to providing such education.

10 January 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
ASAli Sungkar
Ali Sungkar
SBSaptawati Bardosono
Saptawati Bardosono
RIRima Irwinda
Rima Irwinda
NMNurul R. M. Manikam
Nurul R. M. Manikam
RSRini Sekartini
Rini Sekartini
Yvan VandenplasYvan Vandenplas
Yvan Vandenplas
Iron deficiency anemia (IDA) has a long-term impact on each life stage and remains worldwide a major public health problem. Eleven experts were invited to participate in a virtual meeting to discuss the present situation and the available intervention to prevent iron deficiency anemia in Indonesia. The experts consisted of obstetric gynecologists, pediatricians, nutritionists, midwives, a clinical psychologist, and an education expert. Existing interventions focus attention on preconception and early childhood stages. Considering the inter-generational effects of IDA, we call attention to expanding strategies to all life stages through integrating political, educational, and nutritional interventions. The experts agreed that health education and nutritional intervention should be started since adolescence. Further research to explore the effectiveness of these interventions would be important for many regions in the world. The outcome of this Indonesian consensus is applicable worldwide.

14 December 2022 in BMC Public Health
Verified
Journal Article
Open access
PDF file
FAFransisca Handy Agung
Fransisca Handy Agung
RSRini Sekartini
Rini Sekartini
NSNani Cahyani Sudarsono
Nani Cahyani Sudarsono
AHAryono Hendarto
Aryono Hendarto
MDMeita Dhamayanti
Meita Dhamayanti
SSSusan M. Sawyer
Susan M. Sawyer
Background: Obesity and its related cardiovascular-metabolic diseases are growing public health concerns. Despite global attention to obesity, its prevalence is steeply increasing in developing countries, especially in children and adolescents. Eating behaviours and physical activity are modifiable risk factors for obesity that can variably be shaped by families. Eating behaviours and physical activity are especially important during adolescence, given its significance as a foundational period for developing healthy lifestyles. This qualitative study aimed to explore barriers and opportunities around creating healthy lifestyles among adolescents in Indonesia, focussing on family environments from diverse socio-demographic backgrounds. Method: In-depth interviews using a semi-structured guide were undertaken with consecutively recruited 10–18-year-old adolescents with overweight or obesity, and their parents, from three different sites: urban (Jakarta, the capital city of Indonesia), peri-urban (West Java Province) and rural (Banten Province). Thematic analysis was used to identify patterns of meaning. Results: Nineteen dyads were interviewed. Thematic analysis revealed four themes: limited knowledge of healthy lifestyles; healthy lifestyles not a concern of daily life; limited parenting skills, including inequity around gender roles; and aspects of availability and accessibility. These interconnected barriers influenced lifestyle practices at home within the context of daily preferences and decisions around food and activities. Gender role inequity and healthy food accessibility were more prominent in rural families than in those from urban or peri-urban settings. Conclusions: Healthy lifestyles in adolescence may be supported by strategies to enhance parenting skills, build individual motivation, and support the development of more enabling environments.

1 October 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
KSKristiana Siste
Kristiana Siste
JPJacub Pandelaki
Jacub Pandelaki
JMJun Miyata
Jun Miyata
NONaoya Oishi
Naoya Oishi
KTKosuke Tsurumi
Kosuke Tsurumi
KFKarina Kalani Firdaus
Karina Kalani Firdaus
Problematic internet use (PIU) is increasingly recognized as a mental health concern, particularly among adolescents. The resting-state functional connectivity (rsFC) of the triple-network model has been described inconsistently in PIU. Using resting-state fMRI (rsFMRI) and hypothesizing a lower rsFC between default mode (DMN) and central executive networks (CEN) but a higher rsFC within the salience network (SN), this study scrutinized the neural substrates of PIU adolescents. A total of 30 adolescents with PIU and 30 control subjects underwent rsFMRI. The severity of PIU was evaluated by the Internet Addiction Test. Additionally, personality traits as well as emotional and behavioral problems were evaluated by the Temperament and Character Inventory (TCI) and the Strength and Difficulties Questionnaire (SDQ), respectively. Focusing on the DMN, SN, and CEN, we compared rsFC values between PIU and the control. Subsequently, within the combined group of subjects, TCI and SDQ correlation and mediation effects were investigated. Higher rsFC values of the left lateral prefrontal cortex (LPFC(L)) with the left anterior insula (aIns(L)) were observed for PIU than for the control, while rsFCs of the LPFC(L) with the medial PFC (MPFC), LPFC(L), as well as with the right lateral parietal cortex (LP(R)) were lower for PIU. Among these significant group differences, the rsFC between the LPFC(L) and MPFC was mediated by emotional symptoms (standardized β = −0.12, 95% CI −0.29, −0.0052). The dysfunctional attention switching and incentive salience regulated by the SN were implicated as being a neural correlate of PIU, and this relationship would in part be explained by the emotional dysregulation associated with PIU in adolescents.

1 January 2021 in Pediatric Gastroenterology, Hepatology & Nutrition
Verified
Journal Article
Open access
PDF file
BSBudi Setiabudiawan
Budi Setiabudiawan
MSMei Neni Sitaresmi
Mei Neni Sitaresmi
Gartika SapartiniGartika Sapartini
Gartika Sapartini
SUSumadiono
Sumadiono
ECEndah Citraresmi
Endah Citraresmi
JJJuandy Jo
Juandy Jo
Setiabudiawan B, et al. Pediatr Gastroenterol Hepatol Nutr. 2021 May;24(3):316-324. https://doi.org/10.5223/pghn.2021.24.3.316

28 May 2018 in BMC Pediatrics
Verified
Journal Article
Open access
PDF file
HGHartono Gunardi
Hartono Gunardi
KRKusnandi Rusmil
Kusnandi Rusmil
EFEddy Fadlyana
Eddy Fadlyana
SOSoedjatmiko
Soedjatmiko
MDMeita Dhamayanti
Meita Dhamayanti
SHSri Rezeki S. Hadinegoro
Sri Rezeki S. Hadinegoro
The new combination of DTwP-HB-Hib vaccines has been developed in Indonesia following World Health Organization (WHO) recommendation and integrated into national immunization program. The aims of the study were to measure 1) antibody persistence 12–18 months after a primary series, 2) immune response and safety after a booster dose of DTwP-HB-Hib. This was a multi-center, open-labeled, prospective, interventional study. Subjects who had received complete primary dose of DTwP-HB-Hib vaccine from the previous phase III trial were recruited in this trial. Subjects were given one dose of DTwP-HB-Hib (Pentabio®) booster at age 18–24 months old. Diphtheria, tetanus, pertussis, hepatitis B, Hemophilus influenza type B antibodies were measured before and after booster to determine antibody persistence and immune response. Vaccine adverse events were assessed immediately and monitored until 28 days after the booster recorded with parent’s diary cards. There were 396 subjects who completed the study. Increased proportion of seroprotected subjects from pre-booster to post-booster were noted in all vaccine antigens: 74.5 to 99.7% for diphtheria; 100 to 100% for tetanus; 40.4 to 95.5% for pertussis; 90.2 to 99.5% for hepatitis B; and 97.7 to 100% for Hib. Common systemic adverse events (AEs) were irritability (23.7–25%) and fever (39.9–45.2%). Local AEs such as redness, swelling, and induration were significantly less common in the thigh group (7.7, 11.3, and 7.1%) than in the deltoid group (28.9, 30.7, and 25%) (P < 0.001). Most AEs were mild and resolved spontaneously within three-day follow-up period. Booster of DTwP-HB-Hib vaccine at age 18–24 months is required to achieve and maintain optimal protective antibody. The vaccine is safe and immunogenic to be used for booster vaccination. NCT02095314 (retrospectively registered, March 24, 2014).